专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

81. 发明申请

WO2009043457A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009043457A2
公开(公告)日：2009-04-09
申请号：PCT/EP2008007637
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/11 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/12 , A61K38/09 , C07K14/58
摘要： The present invention is directed to the use of the peptide compound Thr-Gly-Lys-Ala- Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly- Leu-Met-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Thr-Gly-Lys-Al-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2作为预防和/或治疗癌症，自身免疫的治疗剂疾病，纤维化疾病，炎性疾病，神经退行性疾病，感染性疾病，肺部疾病，心血管疾病和代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu- Met-NH 2任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

82. 发明申请

WO2009039982A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009039982A2
公开(公告)日：2009-04-02
申请号：PCT/EP2008007530
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/22 , A61K38/33 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/2242 , A23C9/1526 , A23L33/18 , A23L33/40 , A61K38/44 , C12Y114/18001 , A61K2300/00
摘要： The present invention is directed to the use of the peptide compound Tyr-Ala-Glu-Gly- Thr-Phe-lle-Ser-Asp-Tyr-Ser-lle-Ala-Met-Asp-Lys-lle-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-lle-Thr-Gln-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Tyr-Ala-Glu-Gly-Thr-Phe-lle-Ser-Asp-Tyr-Ser-lle-Ala-Met-Asp-Lys-lle-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-lle-Thr-Gln-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Tyr-Ala-Glu-Gly-Thr-Phe-1le-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln- Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Lle-Thr-Gln-OH 用于预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管疾病和代谢疾病的药物。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Tyr-Ala-Glu-Gly-Thr-Phe-Lle-Ser-Asp-Tyr- SER-LLE-ALA-Met的 - 天冬氨酸 - 赖氨酸 - LLE-HIS-GLN-GLN-ASP-PHE-VAL-ASN-TRP-LEU-LEU-丙氨酸 - 谷氨酰胺 - 赖氨酸 - 甘氨酸 - 赖氨酸 - 赖氨酸 - 天冬酰胺 - Asp-的 Trp-Lys-His-Asn-Lle-Thr-Gln-OH任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

83. 发明申请

WO2009033815A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009033815A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008008163
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/08 , A61K38/17 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/08 , A61K38/17
摘要： The present invention is directed to the use of the combination of the peptide compounds Ala-Pro-Gly-Pro-Arg-OH and Lys-Trp-Lys-Leu-Phe-Lys-Lys-lle-Glu-Lys- Val-Gly-Gln-Asn-lle-Arg-Asp-Gly-lle-lle-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln- Ala-Thr-Gln-lle-Ala-Lys-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.
摘要翻译：本发明涉及肽化合物Ala-Pro-Gly-Pro-Arg-OH和Lys-Trp-Lys-Leu-Phe-Lys-Lys-Leu-Glu-Lys-Val-Gly -Gln-Asn-lle-Arg-Asp-Gly-lle-lle-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys -NH2作为预防和/或治疗癌症，心脏和血管疾病，感染性疾病，纤维化疾病，炎性疾病，神经变性疾病或自身免疫性疾病的治疗组合。

84. 发明申请

WO2009033813A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009033813A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008008160
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/29 , A61K38/22 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/22 , A23C9/1526 , A23L33/18 , A23L33/40 , A61K38/29 , A61K2300/00
摘要： The present invention is directed to the use of the combination of the peptide compounds Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-lle-Gln-Asp- Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-lle-Ala-Glu-lle-His-Thr-Ala-OH and VaI- Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp- Ala-Val-Gly-His-Leu-Met-NH2 as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease.
摘要翻译：本发明涉及肽化合物Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-lle-Gln-Asp-Leu -Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ala-Ala-Glu-Ile-His-Thr-Ala-OH和Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly -Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2作为预防和/ 癌症，心脏和血管疾病，感染性疾病，纤维化疾病，炎性疾病，神经变性疾病或自身免疫性疾病。

85. 发明申请

WO2009033799A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用肽作为治疗剂
公开(公告)号：WO2009033799A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008008113
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/09 , A61K38/33 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/12 , A23L33/18 , A23L33/40 , A23V2002/00 , A61K38/22 , A61K2300/00 , A23V2200/308 , A23V2200/318 , A23V2200/322 , A23V2200/324 , A23V2200/326 , A23V2250/55
摘要： The present invention is directed to the use of the peptide compound Pyr-His-Trp-Ser- Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-NHEt optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Pyr-His-Trp-Ser-Tyr-D-Ser（tBu）-Leu-Arg-Pro-NHEt作为治疗剂预防和/或治疗癌症的用途，自身免疫性疾病，纤维化疾病，炎性疾病，神经退行性疾病，感染性疾病，肺病，心脏和血管疾病以及代谢疾病。此外，本发明涉及药物组合物，其优选以冻干物或液体缓冲溶液或人造母乳制剂或母乳代用品的形式存在，所述药物组合物含有肽Pyr-His-Trp-Ser-Tyr-D-Ser（tBu）-Leu-Arg -Pro-NHEt任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起使用。

86. 发明申请

WO2009033787A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用肽作为治疗剂
公开(公告)号：WO2009033787A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008007971
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/35 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/18 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/085 , A61K38/35
摘要： The present invention is directed to the use of the peptide compound Ser-Met-Glu-His- Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys- Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys- Val-Tyr-Pro-OH作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经退行性疾病，感染性疾病，肺病，心脏和血管疾病以及代谢疾病的治疗剂。此外，本发明涉及药物组合物，其优选以冻干物或液体缓冲溶液或人造母乳制剂或母乳代用品的形式存在，所述药物组合物含有肽Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro- Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-OH，以及至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂。

87. 发明申请

WO2009033781A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009033781A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008007965
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/10 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/18 , A61P35/00 , A61P37/00
CPC分类号： A61K38/07
摘要： The present invention is directed to the use of the peptide compound His-Thr-Met-Tyr- Tyr-His-His-Tyr-Gln-His-His-Leu-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His- His-Leu-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及使用肽化合物His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His-His-Leu-OH作为预防和/或治疗癌症的治疗剂，自身免疫性疾病，纤维化疾病，炎症性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管疾病以及代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有His-Thr-Met-Tyr-Tyr-His-His-Tyr-Gln-His- His-Leu-OH任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

88. 发明申请

WO2009033768A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用肽作为治疗剂
公开(公告)号：WO2009033768A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008007882
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/17 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00 , A61P43/00
CPC分类号： A61K38/11
摘要： The present invention is directed to the use of the peptide compound Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH2 as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH2 optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp- Tyr-Ser-Pro-NH 2作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经退行性疾病，感染性疾病，肺病，心脏和血管疾病以及代谢疾病的治疗剂。此外，本发明涉及优选以冻干物或液体缓冲溶液或人造母乳制剂或母乳代用品形式的药物组合物，其含有肽Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe- Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH 2任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

89. 发明申请

WO2009033731A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009033731A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008007668
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/08 , A61K38/39 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P35/00 , A61P37/00
CPC分类号： A61K38/11
摘要： The present invention is directed to the use of the peptide compound Cys-Ser-Arg-Ala- Arg-Lys-Gln-Ala-Ala-Ser-lle-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquide buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Cys-Ser-Arg-Ala-Arg-Lys-Gln-Ala-Ala-Ser- Ile-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Cys-Ser-Arg-Al-Arg-Lys-Gln-Ala-Ala-Ser-Lle-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg- OH作为预防和/或治疗癌症，自身免疫性疾病，纤维化疾病，炎性疾病，神经变性疾病，感染性疾病，肺部疾病，心脏和血管疾病和代谢疾病的治疗剂。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有肽Cys-Ser-Arg-Ala-Arg-Lys-Gln-Ala-Ala-Ser- Ile-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg-OH任选与至少一种药学上可接受的载体，冷冻保护剂，冻干保护剂，赋形剂和/或稀释剂一起。

90. 发明申请

WO2009033666A2 USE OF A PEPTIDE AS A THERAPEUTIC AGENT 审中-公开
标题翻译：使用作为治疗剂的肽
公开(公告)号：WO2009033666A2
公开(公告)日：2009-03-19
申请号：PCT/EP2008007453
申请日：2008-09-09
申请人： MONDOBIOTECH LAB AG , BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
发明人： BEVEC DORIAN , CAVALLI FABIO , CAVALLI VERA , BACHER GERALD
IPC分类号： A61K38/29 , A61P3/00 , A61P9/00 , A61P11/00 , A61P25/28 , A61P31/00 , A61P31/18 , A61P31/20 , A61P35/00 , A61P37/00
CPC分类号： A61K38/10
摘要： The present invention is directed to the use of the peptide compound Ser-Val-Ser-Glu- Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu- Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Ser-Val-Ser-Glu-lle-Gln-Leu-Met-His-Asn- Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp- Val-His-Asn-Phe optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
摘要翻译：本发明涉及肽化合物Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu- Arg-Val-Glu-Trp-Leu- Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe作为预防和/或治疗癌症，自身免疫疾病，纤维化疾病，炎症疾病，神经退行性疾病，传染病，肺部疾病，心血管疾病和代谢疾病。此外，本发明涉及优选形式为冻干物或液体缓冲溶液或人造母乳制剂或含有Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn- Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe 至少一种药学上可接受的载体，低温保护剂，冻干保护剂，赋形剂和/或稀释剂。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式